SG126007A1 - Chemokine receptor binding hetrocyclic compounds - Google Patents

Chemokine receptor binding hetrocyclic compounds

Info

Publication number
SG126007A1
SG126007A1 SG200502184A SG200502184A SG126007A1 SG 126007 A1 SG126007 A1 SG 126007A1 SG 200502184 A SG200502184 A SG 200502184A SG 200502184 A SG200502184 A SG 200502184A SG 126007 A1 SG126007 A1 SG 126007A1
Authority
SG
Singapore
Prior art keywords
receptor binding
chemokine receptor
compounds
hetrocyclic compounds
hetrocyclic
Prior art date
Application number
SG200502184A
Other languages
English (en)
Inventor
Gary Bridger
Renato Skerlj
Al Kaller
Curtis Harwig
David Bogucki
Trevor R Wilson
Jason Crawford
Ernest J Mceachern
Bem Atsma
Nan Siqiao
Zhou Yuanxi
Dominique Schols
Christopher Dennis Smith
Di Maria Rosaria Fluri
Original Assignee
Anormed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anormed Inc filed Critical Anormed Inc
Publication of SG126007A1 publication Critical patent/SG126007A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
SG200502184A 2000-09-15 2001-09-17 Chemokine receptor binding hetrocyclic compounds SG126007A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23289100P 2000-09-15 2000-09-15
US23451000P 2000-09-22 2000-09-22

Publications (1)

Publication Number Publication Date
SG126007A1 true SG126007A1 (en) 2006-10-30

Family

ID=26926422

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200502184A SG126007A1 (en) 2000-09-15 2001-09-17 Chemokine receptor binding hetrocyclic compounds

Country Status (22)

Country Link
US (3) US6864265B2 (no)
EP (1) EP1317445B1 (no)
JP (1) JP2004508422A (no)
KR (1) KR20030029998A (no)
CN (1) CN1457339A (no)
AT (1) ATE425157T1 (no)
AU (2) AU2001291569B2 (no)
BR (1) BR0113930A (no)
CA (1) CA2419224A1 (no)
DE (1) DE60137944D1 (no)
ES (1) ES2325909T3 (no)
HK (1) HK1052011A1 (no)
HU (1) HUP0301093A2 (no)
IL (1) IL154227A0 (no)
MX (1) MXPA03002326A (no)
NO (1) NO20031179D0 (no)
NZ (1) NZ524420A (no)
PL (1) PL360932A1 (no)
RU (1) RU2289581C2 (no)
SG (1) SG126007A1 (no)
TR (1) TR200300322T2 (no)
WO (1) WO2002022600A2 (no)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0113932A (pt) 2000-09-15 2003-06-24 Anormed Inc Compostos heterocìclicos que se ligam ao receptor da quimiocina
PL360932A1 (en) 2000-09-15 2004-09-20 Anormed Inc. Chemokine receptor binding heterocyclic compounds
JP2004508421A (ja) * 2000-09-15 2004-03-18 アノーメッド　インコーポレイティド ケモカインレセプター結合性ヘテロ環式化合物
US7169750B2 (en) 2001-07-31 2007-01-30 Anormed, Inc. Methods to mobilize progenitor/stem cells
PT1411918E (pt) 2001-07-31 2012-03-06 Genzyme Global S A R L Métodos para mobilizar células progenitoras/estaminais
US7354932B2 (en) 2001-12-21 2008-04-08 Anormed, Inc. Chemokine receptor binding heterocyclic compounds with enhanced efficacy
JP4556020B2 (ja) 2001-12-21 2010-10-06 ジェンザイム・コーポレーション 高い有効性を有するケモカインレセプタ結合複素環式化合物
KR100863667B1 (ko) 2002-09-11 2008-10-15 가부시끼가이샤 구레하 아민 화합물 및 그 용도
JP3949708B2 (ja) 2003-04-02 2007-07-25 タイゲン・バイオテクノロジー ケモカイン受容体介在疾患を治療するためのポリアミン化合物
US7504422B2 (en) 2003-04-02 2009-03-17 Taigen Biotechnology Co. Ltd. Polyamine compounds
EP1613613B1 (en) 2003-04-11 2021-06-02 Genzyme Corporation Cxcr4 chemokine receptor binding compounds
US7498323B2 (en) * 2003-04-18 2009-03-03 Ono Pharmaceuticals Co., Ltd. Spiro-piperidine compounds and medicinal use thereof
US7501518B2 (en) 2003-04-22 2009-03-10 Genzyme Corporation Methods of making 2,6-diaryl piperidine derivatives
EP2374804A1 (en) 2003-04-22 2011-10-12 Genzyme Corporation Chemokine receptor binding heterocyclic compounds with enhanced efficacy
CA2534649A1 (en) * 2003-08-01 2005-02-10 Genelabs Technologies, Inc. Bicyclic imidazol derivatives against flaviviridae
US7491735B2 (en) 2003-12-11 2009-02-17 Genzyme Corporation Chemokine receptor binding compounds
US7498346B2 (en) 2003-12-11 2009-03-03 Genzyme Corporation Chemokine receptor binding compounds
JP3977411B2 (ja) 2004-03-10 2007-09-19 株式会社クレハ アミン系塩基性化合物とその用途
BRPI0508703B8 (pt) * 2004-03-15 2021-05-25 Anormed Inc processo para a síntese de um antagonista de cxcr4
AU2005230846A1 (en) * 2004-03-31 2005-10-20 Lexicon Pharmaceuticals, Inc. 2-aminomethylthiazole-5-carboxamides as protein kinase modulators
US20060035829A1 (en) * 2004-08-13 2006-02-16 Anormed Inc. Chemokine combinations to mobilize progenitor/stem cells
US20080045537A1 (en) * 2004-08-16 2008-02-21 Kristjan Gudmundsson Chemical Compounds
CA2577399C (en) * 2004-08-19 2014-07-22 Colgate-Palmolive Company Enhanced oil delivery from structured surfactant formulations
WO2006022454A1 (ja) * 2004-08-27 2006-03-02 Ono Pharmaceutical Co., Ltd 塩基性基を含有する化合物およびその用途
JP2008511669A (ja) * 2004-09-02 2008-04-17 スミスクライン ビーチャム コーポレーション 化合物
EP1793825A4 (en) * 2004-09-24 2009-12-09 Smithkline Beecham Corp CHEMICAL COMPOUNDS
TW200619206A (en) * 2004-09-29 2006-06-16 Anormed Inc Chemokine-binding heterocyclic compound salts, and methods of use thereof
JP2008526980A (ja) * 2005-01-14 2008-07-24 ジェネラブズ テクノロジーズ インコーポレーティッド ウイルス感染症を治療するためのインドール誘導体
US7501526B2 (en) 2005-01-20 2009-03-10 Taigen Biotechnology Synthesis of polyamine compounds
WO2006138350A2 (en) 2005-06-15 2006-12-28 Anormed Inc. Chemokine receptor binding compounds
EP1904501A2 (en) * 2005-07-11 2008-04-02 Smithkline Beecham Corporation Chemical compounds
WO2007022523A2 (en) 2005-08-19 2007-02-22 Genzyme Corporation Methods to enhance chemotherapy
ES2407115T3 (es) * 2005-11-18 2013-06-11 Ono Pharmaceutical Co., Ltd. Compuesto que contiene un grupo básico y uso del mismo
WO2007115232A2 (en) 2006-03-30 2007-10-11 Chemocentryx, Inc. Cxcr4 modulators
US7807704B2 (en) * 2006-03-30 2010-10-05 Chemocentryx, Inc. Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2
JP5257068B2 (ja) * 2006-05-16 2013-08-07 小野薬品工業株式会社 保護されていてもよい酸性基を含有する化合物およびその用途
AU2007281090A1 (en) * 2006-08-02 2008-02-07 Genzyme Corporation Combination therapy
RU2009108289A (ru) * 2006-08-07 2010-09-20 Джензим Корпорейшн (Us) Комбинированная терапия
US20110105477A1 (en) * 2007-09-14 2011-05-05 The Regents Of The University Of Michigan Compositions and methods relating to hiv protease inhibition
ES2420854T3 (es) * 2008-07-02 2013-08-27 F. Hoffmann-La Roche Ag Nuevas fenilpirazinonas como inhibidores de quinasas
ES2477552T3 (es) * 2008-09-08 2014-07-17 The Board Of Trustees Of The Leland Stanford Junior University Moduladores de la actividad de la aldehidodeshidrogenasa y métodos de uso de los mismos
EP2646430B1 (en) 2010-12-03 2016-09-21 Emory University Chemokine cxcr4 receptor modulators and uses related thereto
CN102603683B (zh) * 2012-02-10 2014-04-09 山东大学 一种呋喃类化合物及其制备方法与应用
CN104478795A (zh) * 2014-11-24 2015-04-01 苏州乔纳森新材料科技有限公司 一种2-氯烟醛的制备方法
EP3302710A4 (en) 2015-06-03 2019-02-20 The University of Queensland MOBILIZERS AND USE THEREOF
CN104945313A (zh) * 2015-06-19 2015-09-30 洪帅金 一种2-甲基-3-溴吡啶的制备方法
JP6929276B2 (ja) * 2015-10-06 2021-09-01 プロテオステイシス セラピューティクス，インコーポレイテッド 化合物、医薬的に許容される塩又はその立体異性体及び医薬組成物
CN105198802A (zh) * 2015-11-03 2015-12-30 江苏梦得电镀化学品有限公司 一种2-甲基-3-溴吡啶的制备方法
EP3389652B1 (en) 2015-12-14 2022-09-28 X4 Pharmaceuticals, Inc. Methods for treating cancer
EP3389634B1 (en) 2015-12-14 2021-10-06 X4 Pharmaceuticals, Inc. Methods for treating cancer
SI3393468T1 (sl) 2015-12-22 2023-01-31 X4 Pharmaceuticals, Inc. Postopki za zdravljenje bolezni imunske pomanjkljivosti
CN109153722A (zh) 2016-04-08 2019-01-04 X4 制药有限公司 用于治疗癌症的方法
CN109641838A (zh) 2016-06-21 2019-04-16 X4 制药有限公司 Cxcr4抑制剂及其用途
CN109640988A (zh) 2016-06-21 2019-04-16 X4 制药有限公司 Cxcr4抑制剂及其用途
CN116554168A (zh) 2016-06-21 2023-08-08 X4 制药有限公司 Cxcr4抑制剂及其用途
WO2018073248A1 (en) 2016-10-17 2018-04-26 Icm (Institut Du Cerveau Et De La Moelle Épinière) Prognosis of demyelinating diseases patients and treatment thereof
US10548889B1 (en) 2018-08-31 2020-02-04 X4 Pharmaceuticals, Inc. Compositions of CXCR4 inhibitors and methods of preparation and use
GB201910608D0 (en) * 2019-07-24 2019-09-04 Enterprise Therapeutics Ltd Compounds
CN112110853A (zh) * 2020-09-23 2020-12-22 海南梵圣生物科技有限公司 一种合成3-羟基-2-吡啶甲酸及其衍生物的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001826A (en) * 1989-12-21 1999-12-14 Anormed, Inc. Chemical compounds
US5021409A (en) 1989-12-21 1991-06-04 Johnson Matthey Plc Antiviral cyclic polyamines
GB9126677D0 (en) 1991-12-16 1992-02-12 Johnson Matthey Plc Improvements in chemical compounds
GB9400411D0 (en) 1994-01-11 1994-03-09 Johnson Matthey Plc Improvements in chemical compounds
GB9511357D0 (en) * 1995-06-06 1995-08-02 Johnson Matthey Plc Improved antiviral compounds
BR9810600A (pt) 1997-07-16 2000-07-11 Ciba Sc Holding Ag Compostos espiro-poliglicidila e seu uso em resinas epóxi
WO1999038514A1 (en) * 1998-02-02 1999-08-05 Merck & Co., Inc. Cyclic amine modulators of chemokine receptor activity
JPH11269146A (ja) * 1998-03-24 1999-10-05 Mitsui Chem Inc 分化誘導剤
EP1146790A4 (en) * 1999-01-25 2004-03-17 Smithkline Beecham Corp COMPOUNDS AND METHODS
US6362201B1 (en) * 1999-03-02 2002-03-26 Merck & Co., Inc. 3-cyclopropyl and 3-cyclobutyl pyrrolidine modulators of chemokine receptor activity
JP2003524620A (ja) * 1999-03-24 2003-08-19 アノーメッド インコーポレイティド ケモカインレセプター結合複素環化合物
US6750348B1 (en) * 1999-03-24 2004-06-15 Anormed, Inc. Chemokine receptor binding heterocyclic compounds
PL360932A1 (en) * 2000-09-15 2004-09-20 Anormed Inc. Chemokine receptor binding heterocyclic compounds
JP2004508421A (ja) * 2000-09-15 2004-03-18 アノーメッド　インコーポレイティド ケモカインレセプター結合性ヘテロ環式化合物

Also Published As

Publication number Publication date
US7084155B2 (en) 2006-08-01
CA2419224A1 (en) 2002-03-21
NO20031179L (no) 2003-03-14
US20060128750A1 (en) 2006-06-15
IL154227A0 (en) 2003-07-31
WO2002022600A2 (en) 2002-03-21
WO2002022600A3 (en) 2002-05-10
US6864265B2 (en) 2005-03-08
NO20031179D0 (no) 2003-03-14
US20040220207A1 (en) 2004-11-04
ATE425157T1 (de) 2009-03-15
HUP0301093A2 (hu) 2003-09-29
DE60137944D1 (de) 2009-04-23
US20030018046A1 (en) 2003-01-23
CN1457339A (zh) 2003-11-19
JP2004508422A (ja) 2004-03-18
KR20030029998A (ko) 2003-04-16
RU2289581C2 (ru) 2006-12-20
NZ524420A (en) 2005-04-29
ES2325909T3 (es) 2009-09-24
US7396840B2 (en) 2008-07-08
TR200300322T2 (tr) 2003-09-22
MXPA03002326A (es) 2003-06-06
EP1317445A2 (en) 2003-06-11
BR0113930A (pt) 2003-06-24
AU2001291569B2 (en) 2007-07-26
HK1052011A1 (zh) 2003-08-29
PL360932A1 (en) 2004-09-20
EP1317445B1 (en) 2009-03-11
AU9156901A (en) 2002-03-26

Similar Documents

Publication Publication Date Title
SG126007A1 (en) Chemokine receptor binding hetrocyclic compounds
HK1059257A1 (en) Chemokine receptor binding heterocyclic compounds
MXPA03001143A (es) Derivados de 4-fenil-piridina como antagonistas del receptor de neuroquinina-1.
IL154228A0 (en) Chemokin receptor binding heterocyclic compounds
ZA200409641B (en) Novel substituted indoles.
EP1208085A4 (en) BENZANILIDE AS THE OPENER OF THE POTASSIUM CHANNEL
ZA200205476B (en) Apparatus for mixing.
YU80902A (sh) Novi indolin-2-on derivati, njihovo dobijanje i farmaceuski oblici koji ih sadrže
MXPA03005257A (es) Composiciones frarmaceuticas de un agonista del receptor de nmda.
DK1086082T3 (da) Arylsubstituerede olefiniske aminer og deres anvendelse som cholinerge receptoragonister
EP1708703A4 (en) CHEMOKIN RECEPTOR BINDING COMPOUNDS
IL157654A0 (en) Benzimidazole derivatives which modulate chemokine receptors
HK1042699A1 (en) N-triazolylmethyl-piperazine derivatives as neurokinin receptor antagonists.
MXPA03003892A (es) Antagonistas del receptor bombesin.
HK1059760A1 (en) Fixing device.
GB0028146D0 (en) Bombesin receptor antagonists
WO2002057313A8 (en) Receptor-binding compounds and methods for identifying them
PL370821A1 (en) N-ureido-piperidines as antagonists viii for ccr-3 receptor
IL158063A0 (en) Crf receptor antagonists
ZA200301399B (en) Chemokine receptor binding heterocyclic compounds.
AU2002258679A1 (en) Disruptions in gaba receptor rh02 subunit, methods adn uses thereof
AU9462801A (en) Chemokine receptor binding heterocyclic compounds
PL359523A1 (en) Chemokine receptor binding heterocyclic compounds
AU2002359729A8 (en) Novel g proein-coupled receptor, gave7
ES1042839U (es) Salidas de aire para embudos.